Finally Bristol Myers Squib receives approval from EU for Idecabtagene Vicleucel... May 23
CABENUVA reduces treatment dosing days from 365 to 12 per year ​... Mar 21
Concord,a Lupin alliance partner gets another approval... Dec 20
-Advertisements-